HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination

Oncogene

Volumn 26, Issue 4, 2007, Pages 477-486

  Nakai Murakami, C ^a   Shimura, M ^a   Kinomoto, M ^b   Takizawa, Y ^c   Tokunaga, K ^b   Taguchi, T ^a   Hoshino, S ^a   Miyagawa, K ^d   Sata, T ^b   Kurumizaka, H ^c   Yuo, A ^a   Ishizaka, Y ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c WASEDA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

DNA double strand breaks; HIV 1; Homologous recombination; Non AIDS defining malignancies; Vpr

Indexed keywords

ANTIVIRUS AGENT; ATM PROTEIN; BRCA1 PROTEIN; CHECKPOINT KINASE 2; DOUBLE STRANDED DNA; GENE PRODUCT; HISTONE H2AX; KU 55933; KU 55937; PROTEIN INHIBITOR; RAD51 PROTEIN; UNCLASSIFIED DRUG; VPR PROTEIN;

ARTICLE; CHEMICAL ANALYSIS; CHROMATIN; CONTROLLED STUDY; DNA REPAIR; FIBROSARCOMA; GENE LOCUS; GENOME; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

CELL CYCLE PROTEINS; CELLS, CULTURED; DNA; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE PRODUCTS, VPR; HUMANS; PROTEIN-SERINE-THREONINE KINASES; RECOMBINATION, GENETIC; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33846542073     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209831     Document Type: Article

References (67)

1. Abraham RT. (2001). Genes Dev 15: 2177-2196.
2. Anglana M, Bacchetti S. (1999). Nucleic Acids Res 27: 4276-4281.
3. Bartz SR, Rogel ME, Emerman M. (1996). J Virol 70: 2324-2331.
4. Bertrand P, Saintigny Y, Lopez BS. (2004). Trends Genet 20: 235-243.
5. Biggar RJ, Rosenberg PS, Coté T, Multistate AIDS/Cancer Match Study Group. (1996). Int J Cancer 68: 754-758.
6. Brown EJ, Baltimore D. (2003). Genes Dev 17: 615-628.
7. Bukrinsky M, Adzhubei A. (1999). Rev Med Virol 9: 39-49.
8. Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K et al. (2005). Cancer 104: 1505-1511.
9. Chadburn A, Cesarman E, Knowles DH. (1997). Semin Diagn Pathol 14: 15-26.
10. Cromie GA, Connelly JC, Leach DRF. (2001). Mol Cell 8: 1163-1174.
11. Daniel R, Greger JG, Katz RA, Taganov KD, Wu X, Kappes JC et al. (2004). J Virol 78: 8573-8581.
12. Daniel R, Kao G, Tagarov K, Greger JG, Favorova O, Merkel G et al. (2003). Proc Natl Acad Sci USA 100: 4778-4783.
13. Daniel R, Katz RA, Skalka AM. (1999). Science 284: 644-647.
14. Daniel R, Marusich E, Argyris E, Zhao RY, Skalka AM, Pomerantz RJ. (2005). J Virol 79: 2058-2065.
15. Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK et al. (2003). Mol Cell 12: 1087-1099.
16. Elder RT, Benko Z, Zhao Y. (2002). Front Biosci 7: d349-d357.
17. Elenitoba-Johnson KS, Jaffe ES. (1997). Semin Diagn Pathol 14: 35-47.
18. Goh WC, Rogel ME, Kinsey CM, Michael SF, Fultz PN, Nowak MA et al. (1998). Nat Med 4: 65-71.
19. Groschel B, Bushman F. (2005). J Virol 79: 5695-5704.
20. He J, Choe S, Walker R, Di Marzio PD, Morgan DO, Landau NR. (1995). J Virol 69: 6705-6711.
21. Henklein P, Bruns K, Sherman MP, Tessmer U, Licha K, Kopp J et al. (2000). J Biol Chem 275: 32016-32026.
22. Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin IP, Rabaud C et al. (2003). J Clin Oncol 21: 3447-3453.
23. Hoshino S, Sun B, Shimura M, Konishi M, Taguchi T, Segawa T et al. (2006). submitted.
24. Huang M-B, Weeks O, Zhao L-J, Saltarelli M, Bond VC. (2000). J Neuro Viol 6: 202-220.
25. Huang X, Kurose A, Tanaka T, Traganos F, Dai W, Darzynkiewicz Z. (2006). Cytometer A 69A: 222-229.
26. Ishizaka Y, Chernov MV, Burns CM, Stark GR. (1995). Proc Natl Acad Sci USA 92: 3224-3228.
27. Yamaguchi-Iwai Y, Sonoda E, Buerstedde J-M, Bezzubova O, Morrison C, Takata M et al. (1998). Mol Cell Biol 18: 6430-6435.
28. Jeanson L, Subra F, Vaganay S, Hervy M, Marangoni E, Bourhis J et al. (2002). Virology 300: 100-108.
29. Jenkins Y, McEntee M, Weis K, Greene WC. (1998). J Cell Biol 143: 875-885.
30. Kagawa W, Kurumizaka H, Ikawa S, Yokoyama S, Shibata T. (2001). J Biol Chem 276: 35201-35208.
31. Khanna KK, Jackson SP. (2001). Nat Genet 27: 247-254.
32. Khanna KK, Lavin MF, Jackson SP, Mulhern TD. (2001). Cell Death Differ 8: 1052-1065.
33. Knowles DM. (2003). Hematol Oncol Clin N Am 17: 785-820.
34. Kurumizaka H, Aihara H, Kagawa W, Shibata T, Yokoyama S. (1999). J Mol Biol 291: 537-548.
35. Lai M, Zimmerman ES, Planelles V, Chen J. (2005). J Virol 79: 15443-15451.
36. Lau A, Kanaar R, Jackson SP, O'Connor MJ. (2004). EMBO J 23: 3421-3429.
37. Lau A, Swinbank KM, Ahmed PS, Taylor DL, Jackson SP, Smith GCM et al. (2005). Nat Cell Biol 7: 493-500.
38. Laurence J, Astrin SM. (1991). Proc Natl Acad Sci USA 88: 7635-7639.
39. Levy DN, Refaeli Y, MacGregor RR, Weiner DB. (1994). Proc Natl Acad Sci USA 91: 10873-10877.
40. Li L, Olvera JM, Yoder KE, Mitchell RS, Butler SL, Lieber M et al. (2001). EMBO J 20: 3272-3281.
41. Lim ST, Levine AM. (2005). Curr HIV/AIDS Rep 2: 146-153.
42. Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S et al. (2003). Cancer Res 63: 2596-2605.
43. Mahalingam S, Ayyavoo V, Patel M, Kieber-Emmons T, Kao GD, Muschel RJ et al. (1998). Proc Natl Acad Sci USA 95: 3419-3424.
44. Marmorstein LY, Ouchi T, Aaronson SA. (1998). Proc Natl Acad Sci USA 95: 13869-13874.
45. Mayer V, Ebbesen P, Zachar V. (1995). Eur J Cancer Prev 4: 211-212.
46. Nunnari G, Argyris E, Fang J, Mehlman KE, Pomerantz RJ, Daniel R. (2005). Virology 335: 177-184.
47. O'Connell MJ, Walworth NC, Carr AM. (2000). Trends Cell Biol 10: 296-303.
48. Pierce AJ, Johnson RD, Thompson LH, Jasin M. (1999). Gene Dev 13: 2633-2638.
49. Roshal M, Kim B, Zhu Y, Nghiem P, Planelles V. (2003). J Biol Chem 278: 25879-25886.
50. Sawaya BE, Khalili K, Mercer WE, Denisova L, Amini S. (1998). J Biol Chem 273: 20052-20057.
51. Sengupta S, Linke SP, Pedeux R, Yang Q, Farnsworth J, Garfield SH et al. (2003). EMBO J 22: 1210-1222.
52. Shiloh Y. (2001). Curr Opin Genet Dev 11: 71-77.
53. Shimura M, Onozuka Y, Yamaguchi T, Hatake K, Takaku F, Ishizaka Y. (1999a). Cancer Res 59: 2259-2264.
54. Shimura M, Tanaka Y, Nakamura S, Minemoto Y, Yamashita K, Hatake K et al. (1999b). FASEB J 13: 621-637.
55. Shimura M, Tokunaga K, Konishi M, Sato Y, Kobayashi C, Sata T et al. (2005). AIDS 19: 1434-1438.
56. Slebos RC, Taylor JA. (2001). Biochem Biohpys Res Commun 281: 212-219.
57. Straus DJ. (2001). Curr Oncol Rep 3: 260-265.
58. Tachiwana H, Shimura M, Nakai-Murakami C, Tokunaga K, Takizawa Y, Sata T et al. (2006). Cancer Res 66: 627-631.
59. Taguchi T, Shimura M, Osawa Y, Suzuki Y, Mizoguchi I, Niino K et al. (2004). Biochem Biophys Res Commun 320: 18-26.
60. Tokunaga K, Greenberg ML, Morse MA, Cumming RI, Lyerly HK, Cullen BR. (2001). J Virol 75: 6776-6785.
61. van Gent DC, Hoeijmakers JHJ, Kanaar R. (2001). Nat Rev Genet 2: 196-206.
62. Waldman AS, Liskay RM. (1987). Proc Natl Acad Sci USA 84: 5340-5344.
63. West SC. (2003). Nat Rev Mol Cell Biol 4: 1-11.
64. Yoon D, Wang Y, Stapleford K, Wiesmüller L, Chen J. (2004). J Mol Biol 336: 639-654.
65. Yuan H, Kamata M, Xie Y-M, Chen ISY. (2004). J Virol 78: 8183-8190.
66. Zhang H, Somasundaram K, Peng Y, Tian H, Zhang H, Bi D, Weber BL et al. (1998). Oncogene 16: 1713-1721.
67. Zimmerman ES, Chen J, Andersen JL, Ardon O, DeHart JL, Blackett J et al. (2004). Mol Cell Biol 24: 9286-9294.